
Médecins Sans Frontières Wraps Up Tuberculosis Project in Dushanbe, Tajikistan: A Timeline of Achievements
June 19, 2024Dushanbe, Tajikistan – As Médecins Sans Frontières (MSF) concludes its tuberculosis (TB) project in Dushanbe, Tajikistan, after 13 years of collaboration with the Ministry of Health and Social Protection of Population, we reflect on the programme's journey.MSF’s work in Dushanbe...
Read more
Deepak Shegar: Battling DR-TB with resilience and dreams
June 10, 2024"When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire...
Read more
MSF reveals cost of its landmark TB clinical trial: €34 million
April 26, 2024MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières...
Read more
Myanmar: I have defeated TB and I wish the same for other patients
April 8, 2024Multi-drug resistant tuberculosis is one of the most complex types of tuberculosis you can get. As opposed to drug-sensitive, which responds well to the medication, multi-drug resistant tuberculosis, by its very name, is resistant to some of the drugs used...
Read more
Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis
March 24, 2024Namrata's story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome....
Read more
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
November 15, 2023endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health...
Read more